[Cognitive impairments in metabolic syndrome.]
A A Ivanova1, A A Smirnova2, A Y Taigibova2
1S.M.Kirov Military Medical Academy, 6 Academician Lebedev str., St. Petersburg 194044, Russian Federation,
Advances in Gerontology = Uspekhi Gerontologii
|January 1, 2026
Summary
Metabolic syndrome (MS) and its components may influence cognitive function, but research findings are currently inconsistent. Further large-scale studies are needed to clarify the relationship and develop targeted interventions for cognitive impairment.
Area of Science:
- Neuroscience
- Endocrinology
- Public Health
Background:
- Metabolic syndrome (MS) is a cluster of conditions including hypertension, dyslipidemia, insulin resistance, and abdominal obesity.
- Cognitive dysfunction is a growing concern, and its relationship with MS requires further investigation.
Purpose of the Study:
- To investigate the complex relationship between metabolic syndrome and cognitive dysfunction.
- To explore the impact of individual MS components on cognitive health.
- To identify potential mechanisms linking MS to cognitive impairment.
Main Methods:
- Systematic review and analysis of existing scientific literature.
- Examination of studies focusing on MS as a whole and its independent risk factors.
- Discussion of pathophysiological pathways, including insulin resistance, dyslipidemia, hypertension, and abdominal obesity.
Main Results:
- Current research presents an ambiguous picture regarding the association between MS and cognitive impairment.
- Variability in study methodologies, participant samples, and observation durations contribute to inconsistent findings.
- Evidence suggests that specific components of MS may significantly contribute to cognitive disorders.
Conclusions:
- Clear conclusions on the MS-cognitive dysfunction link are limited due to research heterogeneity.
- Further large-scale, well-designed studies are essential to elucidate the precise mechanisms and extent of MS impact on cognition.
- Findings will inform the development of preventive and therapeutic strategies for cognitive impairment in MS patients.
Related Concept Videos
Overview of Carbohydrate Metabolism
3.2K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
3.2K
Negative and Cognitive Symptoms of Schizophrenia
394
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
394
Overview of Lipid Metabolism
4.7K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.7K
Coronary Artery Disease I: Introduction
846
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
846
Inborn Errors of Metabolism
679
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
679
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K


